雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Systemic cyclosporin therapy in Behçet's disease:Trial of combination with bromocriptine Yasuharu Bando 1 , Satoshi Matsuda 1 , Masahiro Kogiso 1 , Yoshifumi Fujita 1 , Yasuo Mimura 1 1Dept. of Ophthalmology, School of Med, the Univ of Tokushima pp.495-498
Published Date 1988/5/15
DOI https://doi.org/10.11477/mf.1410210367
  • Abstract
  • Look Inside

We treated 13 cases of Behçet's disease with ocular involvement with systemic cyclosporin A. The initial dosis was 4 to 10 mg/kg per day, to be modified later according to the clinical course. The duration of therapy ranged from 3 days to 35 months. Three cases were treated with additional systemic bromocriptine.

Cyclosporin A was effective in 7 out of 9 cases who could tolerate the drug. When cyclosporin A was reduced or discontinued, ocular attacks recur-red in 7, arthritis in 2 and manifestations of entero-Behçet in 1 case. As side effects, we observed renal dysfunction or increased serum creatinine in 4, transient liver dysfunction in 2, mild gastrointesti-nal discomfort in 8, elevated blood pressure in 1, and hypertrichosis in 3 cases. With supplementary bromocriptine, we could reduce the dose of cyclosporin A from 6 mg to 2 mg/kg daily in one case without further ocular attacks.

As an overall evaluation, cyclosporin A was effective in patients who failed to respond to sys-temic colchicine or cyclophosphamide. Due atten-tion seemed to be imperative to its side effects.

Rinsho Ganka (Jpn J Clin Ophthalmol) 42(5) : 495-498, 1988


Copyright © 1988, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有